Table 1.
Baseline Characteristics of the Patients at the initiation of amiodarone infusion
| Variable | Amiodarone treated patients (n = 46) |
|---|---|
| Age (year) | 59.8 ± 11.3a |
| Sex (male) | 23(50.0)b |
| BMI (kg/m2) | 27.4 ± 3.2 |
| SOFA SCORE | 7.24 ± 1.8 |
| PLT (103/μl) | 229.9 ± 85.1 |
| BSA (m2) | 1.93 ± 0.15 |
| HR (bpm) | 118.9 ± 18.7 |
| MAP (mmHg) | 98.4 ± 9.3 |
| CI (l/min/m2) | 3.61 ± 0.94 |
| SVR (dynes/seconds/cm−5) | 1106.8 ± 381.6 |
| SVI (ml/m2/beat) | 31.03 ± 8.5 |
| NE (μ/min) | 10.74 ± 2.9 |
| FTC (milliseconds) | 356.9 ± 78.6 |
| LACTAT (mg/dL) | 24.6 ± 11.5 |
| Comorbidities n (%) | |
| Heart failure | 10 (21%) |
| Diabetes mellitus | 18 (39.1%) |
| Chronic kidney disease | 13 (28.2%) |
| Previous MI | 12 (26%) |
| Previous stroke | 9 (19%) |
| Chronic obstructive pulmonary disease | 1 (2.2%) |
| CRP | 13.13 ± 10.59 |
| GFR (mL/min/1.73 m2) | 78.43 ± 16.56 |
| Cirrhosis | 3 (6.5%) |
BMI: Body mass index, PLT: platelet, BSA: body surface area, HR: heart rate, MAP: mean arterial pressure, CI: cardiac index, SVR: Systemic vascular resistance, SVI: Stroke Volume Index, NE: Norepinephrine, FTC: flow time corrected, MI: myocardial infarction, CRP: c-reactive protein, GFR: Glomerular Filtration Rate
a Mean ± standard deviation, b number (%)